logo unii

pl / en

MEDSILESIA GO GLOBAL 4.0

MedTech4Europe

S3MARTMED

Home > innovation

 

 

The main goal of the MedSilesia Go Global 4.0 project is to approach Polish producers, developers of the ICT bridge, and services that are applicable in the field of health by increasing the internationalization of 11 analysis companies within the MedSilesia Cluster thanks to the opportunities for foreign markets.

 

Activities undertaken as part of the project are closely related to the objectives contained in the strategic documents of the MedSilesia Cluster:

  • wide promotion of the cluster offer and brand on prospective markets,
  • in particular on the markets of the USA, Israel, Austria, Germany, Kazakhstan, Switzerland,
  • building a positive image of the cluster,
  • support for the internationalization of the products of the cluster and its members.

 The project focused on three groups of products / services:

  • IT solutions (ICT in medicine, with particular emphasis on the area of telemedicine, the use of artificial intelligence in medicine, medical imaging, processing and analysis of biomedical information),
  • medical devices, with particular emphasis on equipment for minimally invasive procedures,
  • clinical trials/biocompatibility services.

  Implemented activities:

  • training and consulting support in the field of internationalization of enterprises,
  • participation of cluster members in foreign events (conferences, fairs, economic missions),
  • using the internet platform as a knowledge base supporting the expansion of foreign members of the MedSilesia Cluster.

 Planned effects of the project:

Increase in the value of exports of individual cluster members (project participants);

Increased access to knowledge and best practices from abroad and new markets, and thus a broad customer base;

Intensification of cooperation of individual entities within the MedSilesia Cluster in the field of further growth of entrepreneurship, productivity, creation and commercialization of innovations, knowledge and technology transfer;

Increase in the number of new joint projects within the MedSilesia Cluster, as well as development of cooperation in the field of R&D.

 

Project implementation period: 01/01/2020 – 31/12/2022

 

Total project value: PLN 4 775 930.54

Co-financing of the project from the EU: PLN 3 571 846.49

 

The project is implemented under the Intelligent Development Operational Program 2014-2020, Measure 2.3 Pro-innovative services for enterprises, Sub-measure 2.3.3 Internationalization of the National Key Clusters.

 

“Optimizing the impact of public policies in favor of research and innovation facilities in the field of medical technologies”

 

Upper Silesian Accelerator for Commercial Enterprises Ltd. is one of 9 partners operating in the international MedTech4Europe consortium – for the improvement of instruments supporting research and development infrastructure operating in the field of technology for medicine.

Objective

The main objective of the MedTech4Europe project is to update instruments under regional and national policies, given the growing demand for innovative infrastructure in the field of MedTech sector.

 

Main activities and outputs:

  • State of play of the MedTech sector in each partner’s region;
  • Joint cross-analysis;
  • Self-assessment of regional policies, benchmarking of regional innovation ecosystems, mapping of excellence domains;
  • Study visits and workshops;
  • Local Action Plans.

 Expected results:

  • As a result  of  the exchange of experience between regions and identification of best practices, the partners will be able to implement new solutions to improve their regional policies, in particular:
  • Strengthen the innovation ecosystem for the MedTech sector;
  • Develop business models of RDI infrastructures (Research, Development, and Innovation) giving better access to SME’s;
  • Implement new RDI interregional projects with the identification of complementary excellence domains between regions.

Medical technologies are a key sector for the future in Europe by bringing solutions to reduce healthcare costs in the context of the aging population and one of the key branches of the economy in Europe. Considering demographic changes and an aging population, this sector will require new solutions shortly to reduce health care costs. With the emergence of new and cross-sectoral technologies, it is one of the most innovative technologically advanced sectors that face strong global competition. The only solution and response to changing conditions are innovations in the field of medical technologies. Unfortunately, the med-tech sector is very dispersed, both in terms of products and the enterprises themselves operating in this area. Moreover, the available research and development infrastructure does not always meet the needs and requirements of companies.

With the emergence of new and cross-sectoral technologies, it is one of the most innovative high-tech sectors which faces a strong world competition requiring each time more innovation. In this context, public authorities at regional level need to contribute to strengthening the Research, Development and Innovation ecosystem in favor of innovative medical technology industry in generating economic growth, creating jobs and providing solutions for patients and healthcare systems in the regions

The MedTech4Europe project is implemented as part of the Interreg Europe Program, in cooperation with clusters, business environment institutions, and regional authorities from 8 European countries – from France, Germany, the Netherlands, Denmark, Hungary, Italy, Finland, and Poland.

 

Valuable links:

The project website: https://www.interregeurope.eu/medtech4europe/

Linkedin: https://www.linkedin.com/company/medtech4-europe/

 Library: https://www.interregeurope.eu/medtech4europe/library/

 

 

     

S3MartMed – European Strategic Cluster Partnership for investments in smart specializations in the technological area.

 

 

A new initiative co-financed under the European Union program – COSME, ESPC for investments in smart specializations.

The project will be implemented in the period from 1 October 2018 to 1 October 2020.

  Project partners, 5 clusters:

 

From 2017. 24 regions have joined the S3 Industrial Modernization Platform group dealing with medical technologies. As part of the platform’s activities, regional authorities, clusters, and organizations involved in issues related to regional policy and regional development met regularly to exchange experiences, identify cooperation opportunities and joint initiatives that could be supported under regional S3 strategies. Today, the platform helps the ReConfirm consortium to identify future flagship investment projects at the European level.

5 partner clusters, which are part of the S3 platform, have decided to create a new European Strategic Partnership to contribute to the creation of links and closer interregional cooperation, in particular to the intensification of activities undertaken jointly by research and development units and entrepreneurs (SMEs) in terms of future investments and transfer of medical technologies.

Objective

The main objective of the S3martMed project is therefore to support interregional and intersectoral cooperation in the field of medical technologies – between European clusters and their members from the SME sector. This is to be achieved primarily by the established cluster partnership, webinars on legal regulations in the med-tech area, matchmaking platform, brokerage meetings, consultancy on financing joint research projects, and creating recommendations for regional policies based on developed cooperation models. All activities within the network will be open activities, open to all regions, clusters, and SMEs involved in the S3Medtech platform.

The project website: https://www.clustercollaboration.eu/profile-articles/s3martmed-start-new-european-strategic-cluster-partnership